Antitrophoblast antibodies are associated with recurrent miscarriages

We investigated patients with unexplained recurrent pregnancy loss for expression of antitrophoblast antibodies using choriocarcinoma cell line JEG-3 because these cells retain many characteristics of normal pregnancy-derived trophoblasts.


Nina Rogenhofer, M.D., Robert Ochsenkühn, M.D., Viktoria von Schönfeldt, Ph.D., Rudah Brentano Assef, Christian J. Thaler, M.D., M.I.A.C.

Volume 97, Issue 2 , Pages 361-366.e1



To investigate whether antitrophoblast antibodies are associated with unexplained recurrent miscarriages, we used choriocarcinoma cells JEG-3, since these cells are negative for class I and II antigens, but they do express HLA-G, resembling an antigen expression of endovascular and interstitial trophoblasts.


Case-control study.


Academic research center.


One hundred ninety-four patients with two or more consecutive, idiopathic recurrent miscarriages (RM;


Anti-JEG-3 reactivities were measured by using flow cytometry and comparisons with two in-house standards antibody samples of low and high reactivity.

Main Outcome Measure(s):

Anti-JEG-3 reactivities above the 95% confidence interval of controls were defined as positive.


Sera of RM patients reacted significantly stronger with JEG-3 cells than that of controls. In addition, RM patients significantly more often had positive anti-JEG-3 reactivities (17.5%) than controls 5%. This difference was markedly increased with a subgroup of 80 RM patients who had three or more miscarriages, as 27 of these women (34%) were anti-JEG-3 positive.


Antitrophoblast antibodies show significantly more mean channel shift reactivities, and positive reactivities are significantly more prevalent in RM patients as compared with controls. Such antibodies may be involved in mechanisms affecting pregnancies.

Read the full text at: